Abstract
Magnetic nanoparticles, in combination with applied magnetic fields, can non-invasively focus delivery of small-molecule drugs and human cells to specific regions of the anatomy. This emerging technology could solve one of the main challenges in therapy development: delivery of a high concentration of the therapeutic agent to the target organ or tissue whilst reducing systemic dosing and off-target side effects. Several challenges, however, must be met before this technology can be applied either effectively or safely in the clinic to augment therapies. Multiple nanoparticle features interact to influence the efficiency of magnet-targeted delivery, and so their design will have a large influence on the success of therapeutic targeting. Iron oxide core size and composition affect the type and strength of magnetism, and thus the amount of force that can be applied by an external magnetic field, while particle behaviour within biological systems can be affected by particle size and coating. Preclinical researchers have investigated the use of magnetic targeting-based therapies across a wide range of conditions, and positive results have been reported for both cell and drug delivery applications. Furthermore, magnetic resonance imaging (MRI) can non-invasively monitor the success of targeted delivery—providing high-resolution anatomical information on particle location in preclinical and clinical contexts. In this chapter, we provide a basic introduction to the physical principles behind magnetic targeting technology, relevant design features of nanoparticles and magnetic targeting devices, an overview of preclinical and clinical applications, and an introduction to imaging magnetic particles in vivo.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Pankhurst QA, Connolly J, Jones SK, Dobson J. Applications of magnetic nanoparticles in biomedicine. J Phys D Appl Phys. 2003;36(13):R167–81.
Connell JJ, Patrick PS, Yu Y, Lythgoe MF, Kalber TL. Advanced cell therapies: targeting, tracking and actuation of cells with magnetic particles. Regen Med. 2015;10(6):757–72.
Wilson MW, Kerlan Jr RK, Fidelman NA, Venook AP, LaBerge JM, Koda J, et al. Hepatocellular carcinoma: regional therapy with a magnetic targeted carrier bound to doxorubicin in a dual MR imaging/conventional angiography suite—initial experience with four patients. Radiology. 2004;230(1):287–93.
Lubbe AS, Bergemann C, Riess H, Schriever F, Reichardt P, Possinger K, et al. Clinical experiences with magnetic drug targeting: a phase I study with 4′-epidoxorubicin in 14 patients with advanced solid tumors. Cancer Res. 1996;56(20):4686–93.
Thomas CR, Ferris DP, Lee JH, Choi E, Cho MH, Kim ES, et al. Noninvasive remote-controlled release of drug molecules in vitro using magnetic actuation of mechanized nanoparticles. J Am Chem Soc. 2010;132(31):10623–5.
Cheng K, Shen D, Hensley MT, Middleton R, Sun B, Liu W, et al. Magnetic antibody-linked nanomatchmakers for therapeutic cell targeting. Nat Commun. 2014;5:4880.
Grady MS, Howard 3rd MA, Broaddus WC, Molloy JA, Ritter RC, Quate EG, et al. Magnetic stereotaxis: a technique to deliver stereotactic hyperthermia. Neurosurgery. 1990;27(6):1010–5. discussion 5-6.
Martel S, Mohammadi M, Felfoul O, Lu Z, Pouponneau P. Flagellated magnetotactic bacteria as controlled MRI-trackable propulsion and steering systems for medical nanorobots operating in the human microvasculature. Int J Robotics Res. 2009;28(4):571–82.
Kummer MP, Abbott JJ, Kratochvil BE, Borer R, Sengul A, Nelson BJ. OctoMag: an electromagnetic system for 5-DOF wireless micromanipulation. IEEE Trans Robot. 2010;26(6):1006–17.
Pouponneau P, Soulez G, Beaudoin G, Leroux JC, Martel S. MR imaging of therapeutic magnetic microcarriers guided by magnetic resonance navigation for targeted liver chemoembolization. Cardiovasc Intervent Radiol. 2014;37(3):784–90.
Riegler J, Lau KD, Garcia-Prieto A, Price AN, Richards T, Pankhurst QA, et al. Magnetic cell delivery for peripheral arterial disease: a theoretical framework. Med Phys. 2011;38(7):3932–43.
Nacev A, Beni C, Bruno O, Shapiro B. The behaviors of ferromagnetic nano-particles in and around blood vessels under applied magnetic fields. J Magn Magn Mater. 2011;323(6):651–68.
Krishnan KM. Biomedical nanomagnetics: a spin through possibilities in imaging, diagnostics, and therapy. IEEE Trans Magn. 2010;46(7):2523–58.
Faraudo J, Andreu JS, Camacho J. Understanding diluted dispersions of superparamagnetic particles under strong magnetic fields: a review of concepts, theory and simulations. Soft Matter. 2013;9(29):6654–64.
Song M, Kim YJ, Kim YH, Roh J, Kim SU, Yoon BW. Using a neodymium magnet to target delivery of ferumoxidelabeled human neural stem cells in a rat model of focal cerebral ischemia. Hum Gene Ther. 2010;21(5):603–10.
Kobayashi T, Ochi M, Yanada S, Ishikawa M, Adachi N, Deie M, et al. A novel cell delivery system using magnetically labeled mesenchymal stem cells and an external magnetic device for clinical cartilage repair. Arthroscopy. 2008;24(1):69–76.
Arbab AS, Jordan EK, Wilson LB, Yocum GT, Lewis BK, Frank JA. In vivo trafficking and targeted delivery of magnetically labeled stem cells. Hum Gene Ther. 2004;15(4):351–60.
Sasaki H, Tanaka N, Nakanishi K, Nishida K, Hamasaki T, Yamada K, et al. Therapeutic effects with magnetic targeting of bone marrow stromal cells in a rat spinal cord injury model. Spine. 2011;36(12):933–8.
Kyrtatos PG, Lehtolainen P, Junemann-Ramirez M, Garcia-Prieto A, Price AN, Martin JF, et al. Magnetic tagging increases delivery of circulating progenitors in vascular injury. J Am Coll Cardiol Intv. 2009;2(8):794–802.
Riegler J, Wells JA, Kyrtatos PG, Price AN, Pankhurst QA, Lythgoe MF. Targeted magnetic delivery and tracking of cells using a magnetic resonance imaging system. Biomaterials. 2010;31(20):5366–71.
Kodama A, Kamei N, Kamei G, Kongcharoensombat W, Ohkawa S, Nakabayashi A, et al. In vivo bioluminescence imaging of transplanted bone marrow mesenchymal stromal cells using a magnetic delivery system in a rat fracture model. J Bone Joint Surg Br Vol. 2012;94(7):998–1006.
Shen Y, Liu X, Huang Z, Pei N, Xu J, Li Z, et al. Comparison of magnetic intensities for mesenchymal stem cell targeting therapy on ischemic myocardial repair: high magnetic intensity improves cell retention but has no additional functional benefit. Cell Transplant. 2014;24(10):1981–97.
Oshima S, Kamei N, Nakasa T, Yasunaga Y, Ochi M. Enhancement of muscle repair using human mesenchymal stem cells with a magnetic targeting system in a subchronic muscle injury model. J Orthop Sci. 2014;19(3):478–88.
Vandergriff AC, Hensley TM, Henry ET, Shen D, Anthony S, Zhang J, et al. Magnetic targeting of cardiosphere-derived stem cells with ferumoxytol nanoparticles for treating rats with myocardial infarction. Biomaterials. 2014;35(30):8528–39.
Yanai A, Hafeli UO, Metcalfe AL, Soema P, Addo L, Gregory-Evans CY, et al. Focused magnetic stem cell targeting to the retina using superparamagnetic iron oxide nanoparticles. Cell Transplant. 2012;21(6):1137–48.
Riegler J, Liew A, Hynes SO, Ortega D, O’Brien T, Day RM, et al. Superparamagnetic iron oxide nanoparticle targeting of MSCs in vascular injury. Biomaterials. 2013;34(8):1987–94.
Pislaru SV, Harbuzariu A, Gulati R, Witt T, Sandhu NP, Simari RD, et al. Magnetically targeted endothelial cell localization in stented vessels. J Am Coll Cardiol. 2006;48(9):1839–45.
Kang HJ, Kim JY, Lee HJ, Kim KH, Kim TY, Lee CS, et al. Magnetic bionanoparticle enhances homing of endothelial progenitor cells in mouse hindlimb ischemia. Korean Circ J. 2012;42(6):390–6.
Cheng L, Wang C, Ma X, Wang Q, Cheng Y, Wang H, et al. Multifunctional upconversion nanoparticles for dual-modal imaging-guided stem cell therapy under remote magnetic control. Adv Funct Mater. 2013;23(3):272–80.
Riegler J, Allain B, Cook RJ, Lythgoe MF, Pankhurst QA. Magnetically assisted delivery of cells using a magnetic resonance imaging system. J Phys D: Appl Phys. 2011;44(5).
Mathieu JB, Martel S. Aggregation of magnetic microparticles in the context of targeted therapies actuated by a magnetic resonance imaging system. J Appl Phys. 2009;106(4):44904.
Alksne JF. Stereotactic thrombosis of intracranial aneurysms. N Engl J Med. 1971;284(4):171–4.
Alksne JF, Fingerhut AG, Rand RW. Magnetic probe for the stereotactic thrombosis of intracranial aneurysms. J Neurol Neurosurg Psychiatry. 1967;30(2):159–62.
Nacev A, Kim SH, Rodriguez-Canales J, Tangrea MA, Shapiro B, Emmert-Buck MR. A dynamic magnetic shift method to increase nanoparticle concentration in cancer metastases: a feasibility study using simulations on autopsy specimens. Int J Nanomedicine. 2011;6:2907–23.
Vemulkar T, Mansell R, Petit D, Cowburn RP, Lesniak MS. Highly tunable perpendicularly magnetized synthetic antiferromagnets for biotechnology applications. Appl Phys Lett. 2015;107(1):12403.
Park JH, von Maltzahn G, Zhang LL, Schwartz MP, Ruoslahti E, Bhatia SN, et al. Magnetic iron oxide nanoworms for tumor targeting and imaging. Adv Mater. 2008;20(9):1630.
Wang GK, Inturi S, Serkova NJ, Merkulov S, McCrae K, Russek SE, et al. High-relaxivity superparamagnetic iron oxide nanoworms with decreased immune recognition and long-circulating properties. ACS Nano. 2014;8(12):12437–49.
Yu F, Zhang L, Huang Y, Sun K, David AE, Yang VC. The magnetophoretic mobility and superparamagnetism of core-shell iron oxide nanoparticles with dual targeting and imaging functionality. Biomaterials. 2010;31(22):5842–8.
Yoon TJ, Lee H, Shao HL, Hilderbrand SA, Weissleder R. Multicore assemblies potentiate magnetic properties of biomagnetic nanoparticles. Adv Mater. 2011;23(41):4793.
Paquet C, de Haan HW, Leek DM, Lin HY, Xiang B, Tian GH, et al. Clusters of superparamagnetic iron oxide nanoparticles encapsulated in a hydrogel: a particle architecture generating a synergistic enhancement of the T(2) relaxation. ACS Nano. 2011;5(4):3104–12.
Sanson C, Diou O, Thevenot J, Ibarboure E, Soum A, Brulet A, et al. Doxorubicin loaded magnetic polymersomes: theranostic nanocarriers for mr imaging and magneto-chemotherapy. ACS Nano. 2011;5(2):1122–40.
Fortin-Ripoche JP, Martina MS, Gazeau F, Menager C, Wilhelm C, Bacri JC, et al. Magnetic targeting of magnetoliposomes to solid tumors with MR imaging monitoring in mice: feasibility. Radiology. 2006;239(2):415–24.
Doherty GJ, McMahon HT. Mechanisms of endocytosis. Annu Rev Biochem. 2009;78:857–902.
Zhang S, Gao H, Bao G. Physical principles of nanoparticle cellular endocytosis. ACS Nano. 2015;9:8655–71.
Petros RA, DeSimone JM. Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov. 2010;9(8):615–27.
Gratton SEA, Ropp PA, Pohlhaus PD, Luft JC, Madden VJ, Napier ME, et al. The effect of particle design on cellular internalization pathways. Proc Natl Acad Sci U S A. 2008;105(33):11613–8.
Thorek DLJ, Tsourkas A. Size, charge and concentration dependent uptake of iron oxide particles by non-phagocytic cells. Biomaterials. 2008;29(26):3583–90.
Foged C, Brodin B, Frokjaer S, Sundblad A. Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model. Int J Pharm. 2005;298(2):315–22.
Liu Q, Zhang J, Xia W, Gu H. Magnetic field enhanced cell uptake efficiency of magnetic silica mesoporous nanoparticles. Nanoscale. 2012;4(11):3415–21.
Child HW, Del Pino PA, De La Fuente JM, Hursthouse AS, Stirling D, Mullen M, et al. Working together: the combined application of a magnetic field and penetratin for the delivery of magnetic nanoparticles to cells in 3D. ACS Nano. 2011;5(10):7910–9.
Dobson J. Gene therapy progress and prospects: magnetic nanoparticle-based gene delivery. Gene Ther. 2006;13(4):283–7.
Longmire M, Choyke PL, Kobayashi H. Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomedicine. 2008;3(5):703–17.
Cole AJ, David AE, Wang JX, Galban CJ, Hill HL, Yang VC. Polyethylene glycol modified, cross-linked starchcoated iron oxide nanoparticles for enhanced magnetic tumor targeting. Biomaterials. 2011;32(8):2183–93.
Barenholz Y. Doxil(R)-the first FDA-approved nano-drug: lessons learned. J Contr Release. 2012;160(2):117–34.
Zimmermann U, Pilwat G. Organ specific application of drugs by means of cellular capsule systems (author’s transl). Z Naturforsch C. 1976;31(11–12):732–6.
Wang C, Sun XQ, Cheng L, Yin SN, Yang GB, Li YG, et al. Multifunctional theranostic red blood cells for magnetic-field-enhanced in vivo combination therapy of cancer. Adv Mater. 2014;26(28):4794.
Hu CJ, Fang RH, Wang KC, Luk BT, Thamphiwatana S, Dehaini D, et al. Nanoparticle biointerfacing by platelet membrane cloaking. Nature. 2015.
Pouponneau P, Bringout G, Martel S. Therapeutic magnetic microcarriers guided by magnetic resonance navigation for enhanced liver chemoembilization: a design review. Ann Biomed Eng. 2014;42(5):929–39.
Fang J, Nakamura H, Maeda H. The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev. 2011;63(3):136–51.
Cabral H, Matsumoto Y, Mizuno K, Chen Q, Murakami M, Kimura M, et al. Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size. Nat Nanotechnol. 2011;6(12):815–23.
Chertok B, Moffat BA, David AE, Yu FQ, Bergemann C, Ross BD, et al. Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors. Biomaterials. 2008;29(4):487–96.
Podaru G, Ogden S, Baxter A, Shrestha T, Ren S, Thapa P, et al. Pulsed magnetic field induced fast drug release from magneto liposomes via ultrasound generation. J Phys Chem B. 2014;118(40):11715–22.
Polyak B, Fishbein I, Chorny M, Alferiev I, Williams D, Yellen B, et al. High field gradient targeting of magnetic nanoparticle-loaded endothelial cells to the surfaces of steel stents. Proc Natl Acad Sci U S A. 2008;105(2):698–703.
Shapiro B, Dormer K, Rutel IB. A two-magnet system to push therapeutic nanoparticles. AIP Conf Proc. 2010;1311(1):77–88.
Sarwar A, Lee R, Depireux DA, Shapiro B. Magnetic injection of nanoparticles into rat inner ears at a human head working distance. Ieee T Magn. 2013;49(1):440–52.
Sarwar A, Nemirovski A, Shapiro B. Optimal Halbach permanent magnet designs for maximally pulling and pushing nanoparticles. J Magn Magn Mater. 2012;324(5):742–54.
McNeil RG, Ritter RC, Wang B, Lawson MA, Gillies GT, Wika KG, et al. Functional design features and initial performance characteristics of a magnetic-implant guidance system for stereotactic neurosurgery. IEEE Trans Biomed Eng. 1995;42(8):793–801.
Nacev A, Weinberg IN, Stepanov PY, Kupfer S, Mair LO, Urdaneta MG, et al. Dynamic inversion enables external magnets to concentrate ferromagnetic rods to a central target. Nano Lett. 2015;15(1):359–64.
Muthana M, Kennerley AJ, Hughes R, Fagnano E, Richardson J, Paul M, et al. Directing cell therapy to anatomic target sites in vivo with magnetic resonance targeting. Nat Commun. 2015;6:8009.
Martel S, Mathieu JB, Felfoul O, Chanu A, Aboussouan E, Tamaz S, et al. Automatic navigation of an untethered device in the artery of a living animal using a conventional clinical magnetic resonance imaging system. Appl Phys Lett. 2007;90(11):14105.
Alksne JF, Smith RW. Iron-acrylic compound for steriotaxic aneurysm thrombosis. J Neurosurg. 1977;47(2):137–41.
Turner RD, Rand RW, Bentson JR, Mosso JA. Ferromagnetic silicone necrosis of hypernephromas by selective vascular occlusion to the tumor: a new technique. J Urol. 1975;113(4):455–9.
Kobeiter H, Georgiades CS, Leakakos T, Torbenson M, Hong K, Geschwind JF. Targeted transarterial therapy of Vx-2 rabbit liver tumor with Yttrium-90 labeled ferromagnetic particles using an external magnetic field. Anticancer Res. 2007;27(2):755–60.
Chu KF, Dupuy DE. Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat Rev Cancer. 2014;14(3):199–208.
Gilchrist RK, Medal R, Shorey WD, Hanselman RC, Parrott JC, Taylor CB. Selective inductive heating of lymph nodes. Ann Surg. 1957;146(4):596–606.
Johannsen M, Thiesen B, Wust P, Jordan A. Magnetic nanoparticle hyperthermia for prostate cancer. Int J hyperther. 2010;26(8):790–5.
Maier-Hauff K, Ulrich F, Nestler D, Niehoff H, Wust P, Thiesen B, et al. Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme. J Neuro-Oncol. 2011;103(2):317–24.
Bealle G, Di Corato R, Kolosnjaj-Tabi J, Dupuis V, Clement O, Gazeau F, et al. Ultra magnetic liposomes for MR imaging, targeting, and hyperthermia. Langmuir. 2012;28(32):11834–42.
Jordan A, Wust P, Fahling H, John W, Hinz A, Felix R. Inductive heating of ferrimagnetic particles and magnetic fluids: physical evaluation of their potential for hyperthermia. 1993. Int J Hyperther. 2009;25(7):499–511.
Heathman TR, Nienow AW, McCall MJ, Coopman K, Kara B, Hewitt CJ. The translation of cell-based therapies: clinical landscape and manufacturing challenges. Regen Med. 2015;10(1):49–64.
Fischbach MA, Bluestone JA, Lim WA. Cell-based therapeutics: the next pillar of medicine. Science translational medicine. 2013;5(179):179ps7.
Estelrich J, Escribano E, Queralt J, Busquets MA. Iron oxide nanoparticles for magnetically-guided and magnetically-responsive drug delivery. Int J Mol Sci. 2015;16(4):8070–101.
Senyei AE, Reich SD, Gonczy C, Widder KJ. In vivo kinetics of magnetically targeted low-dose doxorubicin. J Pharm Sci. 1981;70(4):389–91.
Widder KJ, Morris RM, Poore GA, Howard DP, Senyei AE. Selective targeting of magnetic albumin microspheres containing low-dose doxorubicin: total remission in Yoshida sarcoma-bearing rats. Eur J Canc Clin Oncol. 1983;19(1):135–9.
Thiele RH, Colquhoun DA, Gillies GT, Tiouririne M. Manipulation of hyperbaric lidocaine using a weak magnetic field: a pilot study. Anesth Analg. 2012;114(6):1365–7.
Dames P, Gleich B, Flemmer A, Hajek K, Seidl N, Wiekhorst F, et al. Targeted delivery of magnetic aerosol droplets to the lung. Nat Nanotechnol. 2007;2(8):495–9.
Heppner F, Mose JR. The liquefaction (oncolysis) of malignant gliomas by a non pathogenic Clostridium. Acta Neurochir. 1978;42(1–2):123–5.
Schmidt W, Fabricius EM, Schneeweiss U. The tumour-Clostridium phenomenon: 50 years of developmental research (Review). Int J Oncol. 2006;29(6):1479–92.
Forbes NS. Engineering the perfect (bacterial) cancer therapy. Nat Rev Cancer. 2010;10(11):784–93.
Jiang Y, Sigmund F, Reber J, Dean-Ben XL, Glasl S, Kneipp M, et al. Violacein as a genetically-controlled, enzymatically amplified and photobleaching-resistant chromophore for optoacoustic bacterial imaging. Sci Rep. 2015;5:11048.
Martel S, Felfoul O, Mohammadi M, Mathieu JB. Interventional procedure based on nanorobots propelled and steered by flagellated magnetotactic bacteria for direct targeting of tumors in the human body. Conf Proc IEEE Eng Med Biol Soc. 2008;2008:2497–500.
Benoit MR, Mayer D, Barak Y, Chen IY, Hu W, Cheng Z, et al. Visualizing implanted tumors in mice with magnetic resonance imaging using magnetotactic bacteria. Clin Canc Res. 2009;15(16):5170–7.
Alphandery E, Faure S, Seksek O, Guyot F, Chebbi I. Chains of magnetosomes extracted from AMB-1 magnetotactic bacteria for application in alternative magnetic field cancer therapy. ACS Nano. 2011;5(8):6279–96.
Taherkhani S, Mohammadi M, Daoud J, Martel S, Tabrizian M. Covalent binding of nanoliposomes to the surface of magnetotactic bacteria for the synthesis of self-propelled therapeutic agents. ACS Nano. 2014;8(5):5049–60.
Park SJ, Park SH, Cho S, Kim DM, Lee Y, Ko SY, et al. New paradigm for tumor theranostic methodology using bacteria-based microrobot. Sci Rep. 2013;3:3394.
Gadian DG. NMR and its applications to living systems, 2nd Edition. Oxford Science Publications. 1996.
Gleich B, Weizenecker R. Tomographic imaging using the nonlinear response of magnetic particles. Nature. 2005;435(7046):1214–7.
Heyn C, Ronald JA, Ramadan SS, Snir JA, Barry AM, MacKenzie LT, et al. In vivo MRI of cancer cell fate at the single-cell level in a mouse model of breast cancer metastasis to the brain. Magn Reson Med. 2006;56(5):1001–10.
Bauer LM, Situ SF, Griswold MA, Samia AC. Magnetic particle imaging tracers: state-of-the-art and future directions. J Phys Chem Lett. 2015;6(13):2509–17.
Acknowledgments
ML receives funding from Medical Research Council (MR/J013110/1); the King’s College London and UCL Comprehensive Cancer Imaging Centre CR-UK & EPSRC, in association with the MRC and DoH (England); the National Centre for the Replacement, Reduction and Refinement of Animal in Research (NC3Rs); UK Regenerative Medicine Platform Safety Hub (MRC: MR/K026739/1); and Eli Lilly and Company. PS Patrick is funded by UK Regenerative Medicine Platform. TL Kalber is funded by an EPSRC Early Career Fellowship (EP/L006472/1).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Patrick, P.S., Pankhurst, Q.A., Payne, C., Kalber, T.L., Lythgoe, M.F. (2017). Magnet-Targeted Delivery and Imaging. In: Bulte, J., Modo, M. (eds) Design and Applications of Nanoparticles in Biomedical Imaging. Springer, Cham. https://doi.org/10.1007/978-3-319-42169-8_6
Download citation
DOI: https://doi.org/10.1007/978-3-319-42169-8_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-42167-4
Online ISBN: 978-3-319-42169-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)